This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

B. J. WEINBERG, M.D.; C. H. LAWRENCE, M.D.; A. BUCHHOLZ, M.D.

AMA Arch Intern Med. 1954;94(3):493-496.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SCHOENBACH and his co-workers first reported the successful treatment of North American blastomycosis with stilbamidine in 1951.¹ Prior to that time experiences with the toxic effects of stilbamidine had been well documented.* In 1948, Snapper described the effect of 2-hydroxystilbamidine on the course of multiple myeloma. Of particular interest was the lessened toxicity of the 2-hydroxy form of the drug.⁷ Snapper and others, in later work, confirmed this decreased toxicity and later reported the effectiveness of this form of stilbamidine in the treatment of blastomycosis.¹⁰ We would like to add another case of systemic blastomycosis with apparent cure following intensive treatment with 2-hydroxystilbamidine.

REPORT OF A CASE

R. D. M., a 41-year-old white locomotive engineer, was admitted to the dermatologic and medical service at Michael Reese Hospital on April 8, 1953, with a known diagnosis of disseminated blastomycosis. The past history revealed that in 1927 he had . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Departments of Medicine and Dermatology, Michael Reese Hospital, and the University of Illinois.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?